Related references
Note: Only part of the references are listed.Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway
Hsin-Yu Ho et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
Bin Chen et al.
GASTROENTEROLOGY (2017)
Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction
Sung Yong Ahn et al.
ONCOTARGET (2017)
Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells
Myeong-Ok Kim et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Role of protease and protease inhibitors in cancer pathogenesis and treatment
Ali Eatemadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
Shunyan Weng et al.
BMC GASTROENTEROLOGY (2016)
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
Kei Satoh et al.
CLINICAL CANCER RESEARCH (2016)
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
Ran Xu Zhu et al.
GUT AND LIVER (2016)
Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer
Junjun Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family
Mohammed A. Suliman et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer
Junjun Liu et al.
TUMOR BIOLOGY (2016)
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C. Arend et al.
ONCOTARGET (2016)
Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001-2013
Lauren A. Beste et al.
GASTROENTEROLOGY (2015)
Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression
Minoru Tomizawa et al.
ONCOLOGY LETTERS (2015)
CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo
Keun-Woo Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer
M. L. King et al.
ONCOGENE (2015)
CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma
T. Fukusumi et al.
BRITISH JOURNAL OF CANCER (2014)
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Yonghe Li et al.
CANCER LETTERS (2014)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
Shuo You et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Effect of Niclosamide on Basal-like Breast Cancers
Angelina I. Londono-Joshi et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Anticancer Effects of Niclosamide in Human Glioblastoma
Anja Wieland et al.
CLINICAL CANCER RESEARCH (2013)
Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
Jing-Xuan Pan et al.
CHINESE JOURNAL OF CANCER (2012)
Treatment of Hepatocellular Carcinoma: A Systematic Review
Shibo Lin et al.
LIVER CANCER (2012)
Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
Takuya Osada et al.
CANCER RESEARCH (2011)
Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
Ulrike Sack et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Concise Review: Neutral Endopeptidase (CD10): A Multifaceted Environment Actor in Stem Cells, Physiological Mechanisms, and Cancer
Veronique Maguer-Satta et al.
STEM CELLS (2011)
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Yanli Jin et al.
CANCER RESEARCH (2010)
CD10-bearing fibroblast inhibits matrigel invasive potency of interleukin-1α-producing squamous cell carcinoma by diminishing substance P levels in the tumor microenvironment
Lining Xie et al.
CANCER SCIENCE (2010)
MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence
Sujatha Venkataraman et al.
PLOS ONE (2010)
Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients
Achim Fleischmann et al.
CLINICAL CANCER RESEARCH (2008)
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
Elsa F. Velazquez et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Regulation of matrix metalloproteinase gene expression
Chunhong Yan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression
Pei-Ni Chen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation
A Piattelli et al.
ORAL DISEASES (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver
F Lin et al.
DIAGNOSTIC CYTOPATHOLOGY (2004)
CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression
N Bilalovic et al.
MODERN PATHOLOGY (2004)
Molecular mechanisms of tumor invasion and metastasis: An integrated view
RA Cairns et al.
CURRENT MOLECULAR MEDICINE (2003)
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma
SY Xiao et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
